How to Optimize Therapeutic Ratio in Brachytherapy of Head and Neck Squamous Cell Carcinoma?

References

• Ash D. Interstitial therapy. Acta Radiol 1986; 16: 369–93.
   Google Scholar
• Meredith JW. Radium dosage. The Manchester System. Lon-don: Churchill Livingtone, 1967.
   Google Scholar
• Dutreix A, Marinello G. The Paris System. In: Pierquin B, Wilson JF, Chassagne D, eds. Modern brachytherapy. New York: Masson, 1987: 25–42.
   Google Scholar
• Pernot M, Malissard L, Hoffstetter S, et al. The study of tumoral, radiobiological, and general health factors that influ-ence results and complications in a series in 448 oral tongue carcinomas treated exclusively by irradiation. Int .1- Radiat Oncol Biol Phys 1994; 29: 673–9.
   PubMedGoogle Scholar
• Marinello G, Wilson JF, Pierquin B, Barret C, Mazeron JJ. The guide gutter techniques of interstitial implantation and the Paris system of dosimetry. Radiother Oncol 1985; 4: 265–73.
   Google Scholar
• Simon JM, Mazeron JJ, Pohar S, et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993;26: 19–25.
   PubMed Web of Science ®Google Scholar
• Pernot M, Malissard L, Hoffstetter S, et al. Influence of tumoral, radiobiological and general health factors on local control and survival of a series of 361 tumors of the velo-ton-sillar area treated by exclusive irradiation (external beam irradiation + brachytherapy or brachytherapy alone). Int .1-Radiat Oncol Biol Phys 1994; 30: 1021–7.
   Google Scholar
• Puthawala AA, Nysar Syed AM, Eads DL, Neblett D, Gillin L, Gates TC. Limited external irradiation and interstitial 192 Iridium implant in the treatment of squamous cell carcinoma of the tonsillar region. Int .1- Radiat Oncol Biol Phys 1985; 11: 1595–602.
   PubMedGoogle Scholar
• Lee HJ, Zelevsky MJ, Kraus DH, et al. Long term regional control after radiation therapy and neck dissection base of tongue carcinoma. Int .1- Radiat Oncol Biol Phys 1997; 38: 995–1007.
   PubMedGoogle Scholar
• Lusinchi A, Eskandari J, Sun Y, et al. External irradiation plus curietherapy boost in 108 base of tongue carcinomas. Int J Radiat Oncol Biol Phys 1989; 17: 1191–7.
   PubMed Web of Science ®Google Scholar
• Gerbaulet A, Haie-Meder C, Marsiglia H et al. Role of brachytherapy in treatment of head & neck cancers: Institut Gustave Roussy experience with 1140 patients. In: Mould RF, Battermann JJ, Martinez AA, Speiser BL, eds. Brachytherapy. From radium to optimization. [Publisher de-tails please], 1994: 101–31.
   Google Scholar
• Mazeron JJ, Belkacemi Y, Simon JM, et al. Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int .1- Radiat Oncol Biol Phys 1993;27: 251–7.
   PubMed Web of Science ®Google Scholar
• Pemot M, Luporsi E, Hoffsteitter S, et al. Complications following definitive irradiation of the oral cavity and the oropharynx (in a series of 1134 patients). Int .1- Radiat Oncol Biol Phys 1997; 37: 577–85.
   PubMedGoogle Scholar
• Mazeron JJ, Crook JM, Benck V, et al. Iridium 192 im-plantation of Ti and T2 carcinomas of the mobile tongue. Int .1- Radiat Oncol Biol Phys 1990; 19: 1369–76.
   PubMed Web of Science ®Google Scholar
• Mazeron JJ, Grimard L, Raynal M, et al. Iridium-192 for Ti and T2 epidermoid carcinomas of the floor of mouth. Int .1- Radiat Oncol Biol Phys 1990; 18: 1299–306.
   PubMedGoogle Scholar
• Mazeron JJ, Simon JM, Le Pechoux C, et al. Effect of dose rate on local control and complications in definitive irradia-tion of T1-2 squamous cell carcinoma of mobile tongue and floor of mouth with interstitial iridium 192. Radiother Oncol 1991; 21: 39–47.
   PubMed Web of Science ®Google Scholar
• Pierquin B, Chassagne D, Cachin Y, Baillet F, Foumelle Le Buis F. Carcinomes épidermoïdes de la langue mobile et du plancher buccal: etude de 245 cas traites a l'Institut Gus-tave Roussy. Acta Radiol (Ther) 1970; 9: 465–80.
   Google Scholar
• Chu A, Fletcher GH. Incidences and causes of failure to control by irradiation the primary lesion in squamous cell carcinomas of the anterior two thirds of the tongue and floor of mouth. Am J Roentgenol 1973; 117: 502–58.
   Google Scholar
• Benk V, Mazeron JJ, Grimard L, et al. Comparison of curietherapy versus external irradiation in Stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1990; 18: 339–47.
   PubMed Web of Science ®Google Scholar
• Grimard L, Mazeron JJ, Pierquin B. Comparison of curie-therapy versus external irradiation combined with curiethe-rapy in Stage II squamous cell carcinomas of the floor of mouth. Endocur Hypertherm Oncol 1991; 7: 97–110.
   Google Scholar
• Pemot M, Malissart L, Aletti P, Hoffstetter S, Forcard JJ, Bey P. Iridium-192 brachytherapy in the management of 147 T2NO oral tongue carcinomas treated with irradiation alone; comparison of two treatment techniques. Radiother Oncol 1992; 23: 223–8.
   PubMedGoogle Scholar
• Pemot M, Hoffstetter S, Peiffert D, et al. Epidermoid car-cinomas of the floor of mouth treated by exclusive irradia-tion: statistical study of a series of 207 cases. Radiother Oncol 1995; 35: 177–85.
   PubMedGoogle Scholar
• Wendt CD, Peters LJ, Delclos L, et al. Primary radiother-apy in the treatment of Stage I and II oral tongue cancers: importance of the proportion of therapy delivered with in-terstitial therapy. Int J Radiat Oncol Biol Phys 1995; 18: 1287–98.
   Google Scholar
• Mendenhall WM, Parsons JM, Stringer SP, Cassisi NJ, Million RR. T2 oral tongue carcinoma treated with radio-therapy; analysis of local control and complications. Radio-ther Oncol 1989; 16: 275–81.
   Google Scholar
• Paterson R. Studies on optimum radium dosage. Br J Radiol 1952; 25: 505–16.
   PubMed Web of Science ®Google Scholar
• Burgers JMV, Awwad HK. Relation between local cure and dose-time-volume in interstitial implants. Int J Radiat Oncol Biol Phys 1985; 11: 715–23.
   PubMedGoogle Scholar
• Pierquin B, Chassagne D, Baillet F, Paine C. Clinical obser-vations of time factor in interstitial radiotherapy using irid-ium 192. Clin Radiol 1973; 24: 506–9.
   PubMedGoogle Scholar
• Mazeron JJ, Simon JM, Crook J, et al. Influence of dose rate on local control of breast carcinoma treated by exter-nal beam irradiation plus Iridium 192 implant. Int J Radiat Oncol Biol Phys 1991; 21: 1273–7.
   Google Scholar
• Dubray B, Mazeron JJ, Simon JM, et al. Time factor in breast carcinomas: influence of delay between external irra-diation and brachytherapy. Radiother Oncol 1992; 25: 267–72.
   PubMedGoogle Scholar
• Van Limberghen E, van der Schueren E, Van der Bogaert W, Van Wing J. Local control of operable breast cancer after radiotherapy alone. Eur J Cancer 1990; 26: 674–9.
   PubMedGoogle Scholar
• Lambin P, Gerbaulet A, Kramar A. Phase III trial compar-ing two dose rates in brachytherapy of cervix carcinomas: report at two years. Int J Radiat Oncol Biol Phys 1993; 25: 405–12.
   Google Scholar
• Haie-Meder C, Kramar A, Lambin P, Lancar R, Bouzy J, Gerbaulet A. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 1994; 29: 953–60.
   Google Scholar
• Lambin P, Gerbaulet A, Kramar A, Scalliet P, Haie-Meder C, Michel G. A comparison of early effects with low dose rate in brachytherapy of cervix carcinoma in a prospective randomised trial. Eur J Cancer 1994; 30A: 313–20.
   Google Scholar
• Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981–97.
   PubMed Web of Science ®Google Scholar
• Dale RG. The application of the linear quadratic dose ef-fect equation to fractionated and protracted radiotherapy. Br J Radiol 1985; 58: 525–8.
   Google Scholar
• Dutreix J. Expression of dose rate in clinical brachytherapy. Radiother Oncol 1989; 15: 25–37.
   PubMedGoogle Scholar
• Scalliet P, Gerbaulet A, Dubray B. HDR versus LDR gyne-cological brachytherapy revisited. Radiother Oncol 1993; 28: 118–26.
   Google Scholar
• Lau HY, Hay JH, Flores AD, Threlfall WJ. Seven fractions of twice daily high dose-rate brachytherapy for node nega-tive carcinoma of the mobile tongue results in loss of thera-peutic ratio. Radiother Oncol 1996; 39: 19–29.
   PubMedGoogle Scholar
• Inoue T, Teshima T, Murayama S, Shumizutani K, Fuchi-hata H, Furukawa S. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys 1996; 36: 1201–4.
   PubMedGoogle Scholar
• Levendag PC, Schmitz PIM, Jansen PJ. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997; 38: 497–506.
   Google Scholar
• Van Eijkeiren M, Thienpont M, Boterberg T, De Neve W. Implementation, uptime, and safety of pulsed dose rate af-terloading machine. Int J Radiat Oncol Biol Phys 1996; 36: 1233–7.
   PubMedGoogle Scholar
• Fowler JF, Van Limberghen EFM. Radiobiological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997; 37: 877–83.
   PubMedGoogle Scholar
• Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1991; 20: 181–90.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ, Huang Y, Sachs RK. Optimizing the time course and other accelerated radiotherapeutic proto-cols. Int J Radiat Oncol Biol Phys 1994; 29: 893–901.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Mount M. Pulsed brachytherapy. The condi-tions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992; 23: 661–9.
   Google Scholar
• Armour E, Wang ZH, Corry P, Martinez A. Equivalence of continuous and pulse simulated low dose rate in 9L glioblastoma cells at 37 degrees and 41 degrees. Int J Ra-diat Oncol Biol Phys 1992; 22: 10–4.
   Google Scholar
• Mason KA, Thames HD, Gehran T, Janjan N. Comparison of continuous and pulsed low-dose-rate brachytherapy. Bio-logical equivalence in vitro. Int J Radiat Oncol Biol Phys 1994; 28: 687–91.
   Google Scholar
• Brenner DJ, Hall ED, Randers-Pehrson G, et al. Quantitative comparison of continuous and pulsed low dose rate regimens in a model late effect system. Int .1- Radiat Oncol Biol Phys 1996; 34: 905–10.
   Google Scholar
• Fritz P, Weber KJ, Frank C, Flentje M. Differential effects of dose rate and superfractionation on survival and cell cycle of V79 cells from spheroid and monolayer culture. Radiother Oncol 1996; 39: 73–9.
   PubMed Web of Science ®Google Scholar
• Armour EP, White JR, Armin A, et al. Pulsed dose rate brachytherapy in a rat model: dependence of late rectal injury on radiation pulse size. Int .1- Radiat Oncol Biol Phys 1997; 38: 825–34.
   PubMedGoogle Scholar
• Visser AG, van den Aardweg GJMG, Levendag PC. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments. Int .1- Radiat Oncol Biol Phys 1996; 34: 497–505.
   PubMedGoogle Scholar
• Sehti T, Ash DV, Flynn A, Workman G. Replacement of hairpin and loop implants by optimised straight line sources. Radiother Oncol 1996; 39: 117–21.
   PubMedGoogle Scholar
• Mazeron JJ, Boisserie G, Baltas D. Pulsed dose rate brachytherapy: a survey. Curr Oncol 1997; 4 (Suppl 1): 4–6.
   Google Scholar
• Swift PS, Purser P, Roberts LW, Pickett B, Powell CB, Philips TL. Pulsed dose rate brachytherapy for pelvic malig-nancies. Int .1- Radiat Oncol Biol Phys 1997; 37: 81–7.
   Google Scholar
• Vandenbrouck C, Sancho-Gamier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic neck dissection in epidermoid carcinoma of the oral cavity. Cancer 1980; 46: 386–90.
   PubMed Web of Science ®Google Scholar
• Piedbois P, Mazeron JJ, Haddad E, et al. Stage I—II squamous cell carcinoma of the oral cavity treated by Iridium 192: is elective dissection indicated? Radiother Oncol 1991; 21: 100–7.
   PubMedGoogle Scholar